| Code | 7891A | ||||||||||
| MA number | 15/0325/11-S | ||||||||||
| Product Form: | plc ifc 10x1x1000 mg (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Fresenius Kabi s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 13.05.2011 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Vancomycin Kabi 500+1000mg plc ifc_03.2022.pdf
|
| SPC: |
SPC_Vancomycin Kabi 1000mg plc ifc_03.2022.pdf
|
| Safety feature | Yes |
| Data update: | 31.03.2022 |
